Kimberly-Clark May Sell Assets to Save Its $40 Billion Kenvue Deal: Report
Kimberly-Clark prepares EU concessions to win approval for its $40B Kenvue deal, following Australian divestiture demands.
Stocks · News reference
B of A Securities Maintains Buy on Kimberly-Clark, Lowers Price Target to $120
B of A Securities analyst Anna Lizzul maintains Kimberly-Clark (NASDAQ:KMB) with a Buy and lowers the price target from $122 to $120.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Here's My Pick for the Smartest High-Yield Dividend Stock to Buy Right Now
Kenvue (KVUE) is highlighted as a smart high-yield dividend stock with a 4.68% dividend yield and 64 consecutive years of dividend increases, making it a Dividend King. The company, spun off from Johnson & Johnson three years ago, generates steady revenue from recession-resilient consumer healthcare brands like Tylenol and Neutrogena. However, uncertainty exists due to a pending acquisition by Kimberly-Clark (KMB), another Dividend King with a 5.23% yield.
Delta Air, Freeport-McMoRan, Kimberly-Clark And More On CNBC’s ‘Final Trades’
CNBC traders picked Freeport-McMoRan, iShares Energy ETF, Delta Air Lines and Kimberly-Clark as final trades, citing earnings, energy, travel and yield.